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Abstract 
Critically ill patients commonly require multiple medical devices such as cardiac monitors, 
ventilators, non-invasive positive pressure ventilators, nasal gastric tubes (NG), orogastric 
tubes (OG), and urinary tract catheters. Nurses are challenged to prevent hospital acquired 
pressure ulcers (HAPUs) because many of these devices can cause ulcers on bony 
prominences and mucosa. The literature indicates that medical device-related pressure ulcers 
(MDRPUs) associated with endotracheal tube (ETT) were the most frequent (Coyer, F., 
Stotts, N. & Blackman, V., 2014; Hanonu & Karadag, 2016), with highest rates of MDRPUs 
were observed among Medical Intensive Care Unit (MICU) patients (Hanonu & Karadag, 
2016). The purpose of this study was to explore the effects of ETT pressure and ETT 
repositioning frequency on oral mucosa microcirculation among intubated patients to guide 
clinicians in the prediction and prevention of oral mucosa pressure ulcers (OMPrU).  
 A single-site, prospective, descriptive, observational study was conducted with a 
convenient sample of six patients who were enrolled between January 7, 2016 and June 30, 
2016.  Age, vital signs (including body temperature, heart rate (HR), mean arterial pressure 
(MAP)) , Sequential Organ Failure Assessment (SOFA) score, usage of anticoagulant, usage 
of pressor, total capillary density (TCD), functional capillary density (FCD), the percentage 
of perfused and non-perfused capillary loops (PPC) and microvascular flow index (MFI) 
were measured to address three research questions: What microcirculation changes of upper 
lip oral mucosa occur from ETT pressure every two hours upon ETT repositioning during the 
first eight hours of intubation using the ETT holder, AnchorFast?; What relationships exist 
between participants’ vital signs and oral mucosal microcirculation?; What relationship exists 
between participants’ age, SOFA score, and Braden Scale for Predicting Pressure Sore Risk 
(BSPPSR) and final 8-hour vital signs and final 8-hour oral mucosal microcirculation?   
 This study provides additional evidence to support current practice of ETT 
repositioning every 4 hours. Future research on oral mucosa microcirculation in context of 
ETT-related pressure ulcer prevention should address the relationship of oral mucosa 
microcirculation including other variables such as patients’ underlying medical diagnoses, 
BSPPSR subscale, choice of sedation medication, gender, and angle of ETT.   
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Chapter 1: Introduction 
 Disclosure 
 Although the study used AnchorFast® as endotracheal tube (ETT) securement, this 
research was not funded by its manufacturer, Hollister Incorporated. 
Problem 
  Florence Nightingale recognized traditional pressure ulcers on bony prominences as a 
preventable injury and a nursing responsibility nearly two centuries ago (Nightingale, 1860). 
Pressure ulcers (PrUs) are defined as “any area of localized damage to the skin and 
underlying tissue caused by pressure, shear, or friction, or a combination of these actions” 
(Haessier, 2014). Critically ill patients are at high risk of development of PrUs due to their 
unstable medical condition and the invasive nature of the many interventions and therapies 
they receive (Tayyib, Coyer & Lewis, 2013). Critically ill patients commonly require 
multiple medical devices such as cardiac monitors, ventilators, non-invasive positive pressure 
ventilators, nasal gastric tubes (NG), orogastric tubes (OG), and urinary tract catheters. 
Critical care nurses are challenged to prevent hospital acquired pressure ulcers (HAPUs) 
because many of these medical devices are required to treat patients in intensive care units 
(ICU). 
HAPUs pose a significant problem in elderly and critically ill patients by causing 
pain, decreasing quality of life, leading to significant morbidity, and prolonging hospital 
stays. In a study by the Institute for Healthcare Improvement (IHI, 2006), approximately 2.5 
million patients are treated for pressure ulcers in US health acute care facilities each year. 
The estimated cost of individual patient care ranges from $20,900-$151,700 per pressure 
ulcer (IHI, 2006), and the total cost for treatment of pressure ulcers in the US healthcare 
system is estimated at $9.1-$11.6 billion per year (Berlowitz et al., 2014). 
  Mucosal pressure ulcers (MPrUs) are a relatively new phenomenon (National 
Pressure Ulcer Advisory Panel (NPUAP), 2008). Unlike traditional pressure ulcers which are 
localized injury to the skin and/or underlying tissue over bony prominences 
(www.NPUAP.org, 2014), MPrU occurs on mucosal membrane where no bony prominences 
are involved. In August 2008, the NPUAP recognized that pressure ulcers could occur not 
only over bony prominences but also on any tissue under pressure, especially from medical 
devices. The NPUAP released a position statement and defined that MPrUs are “found on 
mucous membranes with a history of a medical device, such as oxygen tubing, endotracheal 
tubes, bite blocks, orogastric and nasogastric tubes, urinary catheters and fecal containment 
devices, in use at the location of the ulcer” (“Mucosal Pressure Ulcers”, 2011). 
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The majority of medical device-related pressure ulcers (MDRPUs) are oral mucosal 
pressure ulcers (OMPrUs) attributed to endotracheal tubes (ETTs) in critical care units.  One 
of the risks of endotracheal intubation is the development of skin and oral mucosal pressure 
ulcers (OMPrUs) that result from direct pressure to inner oral mucosa and lips due to tight 
securement of the ETT over a period of time. In particular, OMPrUs have broad implications 
for the patient and the hospital. Negative outcomes include wounds requiring surgical 
intervention, increased risk of infection, increased length of stay, and patient body image 
disturbance. Liu et al (2010) study of 509 Chinese subjects found respiratory complications 
due to ETT in post-op patients including tracheal mucosa damage. In addition, laryngeal 
injury including inflammation and edema, mucosal ulceration, granulomas, vocal cord 
paralysis, and laryngeal tracheal stenosis are all complications associated with ETT 
placement (Hyzy, 2017). The new requirements for reporting nosocomial pressure ulcers 
have redefined the way we approach securing ETT and providing safe care (Hollister, 2013, 
p.2). 
Specific Data Related to Medical Device Related Pressure Ulcers 
MDRPUs have become more evident as traditional pressure ulcers are trending down 
(Apold & Rydrych, 2012), and patients with medical devices are 2.4 times more likely to 
develop a pressure ulcer of any kind than those without medical devices (Black et al., 2010). 
Among MDRPUs, OMPrUs are more frequent among adult critically ill patients. OMPrUs 
related to ETTs are found on labial mucus membranes of the upper or lower lip. Researchers 
have identified further systematic investigation is needed to determine how long any device 
can be in place before it needs to be moved or removed, and how often to examine the skin 
should be examined (Black et al., 2010). 
An important quality indicator at the Queen’s Medical Center (QMC) in Honolulu, 
Hawai`i is quarterly prevalence rates of HAPUs. Consistent with Black et al.’s findings 
(2010), numbers of MDRPUs have increased at QMC from 9 in fiscal year 2010 to 23 in 
2014 (see Table 1). 
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Table 1. Number of Device Related Pressure Ulcers at QMC 
 
Of the pressure ulcers reported at the QMC Medical Intensive Care Unit (MICU) and 
Surgical Intensive Care Unit (SICU) in December 2014, four HAPUs were identified, and all 
were MDRPUs.  Two of these four MDRPUs were OMPrUs and resulted from ETTs; one 
resulted from a tracheostomy collar and the other resulted from a NG tube. Exploring the 
effects of ETT pressure on oral mucosa microcirculation and effects of ETT placement 
duration and reposition intervals will guide the development of practices that prevent 
OMPrU.  
Significance 
 Pressure ulcers affect physical and psychosocial function and impose a financial 
burden on the patient’s family and society (Wong & Stotts, 2003). Avoiding MDRPUs 
among critically ill patients is often more complicated than preventing those related to bony-
prominences because the medical device is usually an essential diagnostic/therapeutic 
component of treatment (Fletcher, 2012).  
 The prevention of pressure ulcers has long been considered to be within the domain of 
nursing practice. Pressure ulcers may occur in spite of a proper position change regimen and 
meticulous nursing care. The nursing goal of eliminating external pressure to prevent 
pressure ulcers often translates as a failure of nursing care when patients develop pressure 
ulcers. Research has identified the interruption of soft tissue microcirculation as having a 
significant role in the development of pressure ulcers and the exact mechanisms still remain 
unclear (Tsuji, Ishioka, Sekiya & Nakatsuka, 2005).  
Key Problem Area: Lack of Knowledge About Prevention of OMPrUs  
 Minimal research has been published on OMPrU prevention. Research on ETTs and 
other device-related OMPrUs has compared ETT securement with conventional tape and 
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holders. Kaplow and Bookbinder (1994) compared four ETT holders and standard method 
with tape.  The study suggested that the SecureEasy holder was the preferred method for 
securing ETT for ETT stability, facial skin integrity, patients’ and registered nurses’ 
satisfaction compared to tape. A case study by Yamashita, Nishio, Daizo, Kishibe & Shimada 
(2014) reported that 2 patients developed an intraoperative PrU on the lower lip where an 
ETT was secured with polyurethane film for over 270 minutes during rhinoplasty. Nurses’ 
anecdotal evidence on the difficulty of oral mucosal assessment and oral care using adhesive 
tape, inconsistent rotation of ETT position, and tightness of ETT securement, are important 
reasons to reassess the current practice of ETT management at QMC.  
 Studies on MDRPUs indicate that MDRPUs occurred more than non-MDRPUs 
among critically ill patients, and the most frequent MDRPU was ETT-related OMPrU (Black 
et al, 2010; Chun, 2014; Coyer, Stotts & Blackman, 2014; Hanonu & Karadag, 2016). 
Although awareness of MDRPUs on oral mucosa has increased, research on understanding 
oral mucosa changes due to pressure, friction and shearing from ETT is scant. 
Chapter 1 Summary 
Research literatures continues to suggest that MDRPUs have become more evident. 
As traditional pressure ulcers are trending down, patients with medical devices are 2.4 times 
more likely to develop a pressure ulcer of any kind than those without medical devices 
(Apold & Rydrych, 2012; Black et al., 2010). Despite the recent awareness of MDRPUs, and 
the fact that ETT-related OMPrU are the most frequent MDRPU, there is little research to 
guide nurses to prevent ETT-related OMPrU.  Further research is essential to explore and 
better understand oral mucosal microcirculation in the context of ETT-related pressure ulcer 
development.   
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Chapter 2. Review of Literature 
Introduction 
Microcirculation is readily and frequently used by healthcare professionals, and its 
meaning is assumed to be clear and universally understood.  However, the interpretation of 
microcirculation is uniquely personal due to the individuals’ intrinsic and extrinsic factors 
and varies among different body parts.  Microcirculation in the context of pressure ulcer 
development is a fundamental concept to understand the development of pressure ulcer 
“pathomechanically” and “pathophysiologically” because interruption of microcirculation 
plays a significant role (Tsuji et al., 2005).   
 OMPrUs in medical intensive care unit (MICU) are becoming more prevalent and 
require further exploration in terms of ETT placement, which causes mucosal membrane 
pressure injury. Further description of this phenomena is needed in order to develop 
preventive interventions to improve patient outcomes.  The purpose of this literature review 
was to define microcirculation, describe ETT-related pressure ulcers, and describe several 
components of the labial mucosa: characteristics of the labial mucosa, physiological 
determinants affecting labial mucosa microcirculation and environmental determinants 
affecting labial mucosa microcirculation. 
Literature Review   
 Literature was obtained using computerized searches of PubMed Medline, CINAHL, 
and Google Scholar for the years 1987-2016. Additional sources were obtained after 
reviewing the bibliographies of the literature identified by the initial search. The terms of 
‘device related pressure ulcers’, ‘endotracheal tube related pressure ulcer’, ‘microcirculation’, 
‘upper lip’, ‘lips’, ‘labial mucosa’, ‘pressure injury ’and ‘mucosal pressure ulcer’ were used. 
These terms evolved from the reading of pressure relief research to optimize microcirculation 
to prevent pressure ulcers. Any references published in English or translated into English 
were included. Research studies on humans were included. This initial literature search 
covered 25 published reports on labial mucosa microcirculation.    
 Definition of microcirculation.  
 Microcirculation is a combination of words “micro” and “circulation” and the origin 
of these two words are from 1955 to 1960 (Dictionary.com Unabridged, 2010).  Micro was 
derived from the Greek word “mīkrós” and is a combining form with the meaning “small”.  
Circulation was derived from the Latin word “circulationem” from cirulare “to form a circle” 
“from circulus” and it was first used in relation to blood by William Harvey in 1628 (Online 
Ethymology Dictionary, 2010).  Circulation is defined as a noun and is described as a) “an act 
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or instance of circulating, moving in a circle or circuit, or flowing”; b) “the continuous 
movement of blood through the heart and blood vessels, which is maintained chiefly by the 
action of the heart, and by which nutrients, oxygen, and internal secretions are carried to and 
wastes are carried from the body tissues”; c) “any similar circuit, passage, or flow, as of the 
sap in plants or air currents in a room”; d) “the transmission or passage of anything from 
place to place or person to person: the circulation of a rumor; the circulation of money”; e) 
“the distribution of copies of a periodical among readers”; f) “the number of copies of each 
issue of a newspaper, magazine, etc., distributed”; and g) “coins, notes, bills, etc., in use as 
money” (Dictionary.com Unabridged, 2010).   
 When these two words, “micro” and “circulation”, are combined and used as one 
word, its meaning becomes more specific towards a scientific definition. As one word, 
microcirculation is described as “the movement of blood through the arterioles, capillaries, 
and venules” (Dictionary.com Unabridged, 2010).  Other sources define microcirculation as 
a) “blood circulation in the microvascular system or the microvascular system itself” 
(Merriam-Webster's Medical Dictionary, 2007); b)  “the flow of blood or lymph through the 
smallest vessels of the body, especially as the venules, capillaries, and arterioles” (The 
American Heritage Stedman's Medical Dictionary, 2002); and c) “the small vessels in the 
vasculature which are embedded within organs and are responsible for the distribution of 
blood within tissues” (Wikipedia, 2010). Microcirculation involves extremely small vessels 
(10-100 µm in diameter) (Wikipedia, 2010; Lipowsky, 2005; Tuma, Duncan, & Ley, 2008); 
innervated blood vessels (Wikipedia, Tuma et al., 2008); regulation of blood flow, tissue 
perfusion, blood pressure, tissue fluid, delivery of oxygen and other nutrients, removal of 
CO2 , oxygen free radicals, and other metabolic waste products, body temperature (Lipowsky, 
2005); and important role in inflammation (Trzeciak and Rivers, 2005) 
In general, there is a tremendous amount of research done on pressure ulcers, starting 
with Kosiak’s 1958 study.  Recent pressure ulcer studies are evolving as they now examine 
the changes associated with superficial structures of the skin to much more complex 
structures, such as microcirculation of both skin and muscles (Salcido, Popescu & Ahn, 
2007). Although a large body of knowledge exist on pressure ulcers, very few research 
studies on microcirculation in the context of pressure ulcers exists, as focus in this area did 
not start until the 1990’s.  “Given the magnitude of the problem, it is notable that there 
remains a paucity of research and a corresponding evidence base for our practices. Pressure 
ulcer research remains in its infancy” (Salcido et al., 2007). 
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ETT-related pressure ulcers. 
The literature indicated that ETT-related MDRPUs were the most frequent (Coyer et 
al., 2014; Hanonu & Karadag, 2016) and the highest rates of MDRPUs were observed among 
medical ICU patients (Hanonu & Karadag, 2016). The retrospective study by Zaratkiewicz et 
al. (2010) showed that AnchorFast with Universal Bite Block decreased ETT-related mucosal 
pressure ulcers.  Cooper (2013) also noted ETT pressure could cause pressure ulcers on a 
patient’s lips, and failure to follow manufacturers’ recommendations for endotracheal 
securement on appropriate patients (patients without facial edema, lip edema, protruding 
teeth) and repositioning ETT every 2 hours could lead to oral mucosa pressure ulcer.   
 Characteristics of labial mucosa.  
 The upper lip mucosa is defined as the inner aspect of the lips covering the maxillary 
jaw region and dentition.  This region is called labial mucosa, which is one type of non-
keratinized lining mucosa that has a softer texture, moist surface and ability to stretch and be 
compressed, acting as a cushion for the underlying structures (https://pocketdentistry.com/9-
oral-mucosa/, 2015), and lips are pliable because of no bones and no infrastructure (Madhav 
& Ojha, 2012).   
 Scardina and Messina (2003) studied microcirculation of the lower lip in healthy 
subjects using computerized video-microscopic techniques that measured visibility of the 
capillary loops, orientation with respect to the surface, capillary density, capillary tortuosity, 
microhemorrhages, characteristics of the capillary loops, number of visible capillary loops in 
every square millimeter.  These authors determined that the characteristics of the lower lip 
are composed of a network of capillaries in polygonal mesh and a parallel orientation with 
respect to the surface. The tortuosity of the capillaries (crossing of capillaries) are limited to 
the lip region.  Furthermore, micro-hemorrhages were noticed in the lower lip mucosa that 
could have been possibly caused by microtraumas.  Capillary loops have variable diameters, 
courses, and lengths, and have shapes like a horse stirrup, hairpins, commas and candle 
holders with multiple arms. Yu et al. (1994) also found that labial mucosa capillaries had a 
simple hairpin shape originating directly from the subpapillary vascular work. 
 Physiological determinants affecting labial mucosa microcirculation. 
 Age, body temperature, heart rate and blood pressure affect tissue tolerance for 
pressure and oxygen concentration changes (Keller, Wille, Ramshortst, & Werken, 2002). 
Bergstrom & Braden’s (1992) study showed that older age subjects with lower systolic and 
diastolic blood pressure and higher body temperature developed pressure ulcers. 
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 Nakagawa et al. (2011) found negative correlations between age and distensibility of 
the lower labial mucosa, and between age and moisture content of the lower labial mucosa.  
Scardina & Messina (2012) examined oral microcirculation of 27 women in pre and post 
menopause. The study showed post-menopausal women showed decrease in diameter of 
loops and increase in tortuosity in oral labial mucosa, which may indicate a greater 
permanence of inflammatory factors. Townsend et al. (2015) found that there was an 
increased influx of red blood cells (RBC) containing oxygenated hemoglobin flowing 
through the loop during systole, and this was more evident in the labial tissues.  On imaging, 
the investigators propose that the dilated capillary loops and reduced oxygen exchange were 
determined to be associated with the development of longer capillary loops that lead to 
periodontal breakdown, and that this may possibly be an early sign of inflammation.  
Systemic sclerosis, Sjogren’s syndrome, burning mouth syndrome, and smoking 
showed evident alteration in the capillaries (Grassi et al, 1993; Scardina & Messina, 2004; 
Scardina et al., 2008; Scardina et al., 2009; Scardina et al., 2011). 
 Environmental determinants affecting labial mucosa microcirculation. 
Retrospective studies were conducted to describe the human, product, and 
environmental factors that might contribute to MDPrUs. A retrospective study by 
Zaratkiewicz et al. (2010) showed that AnchorFast with Universal Bite Block decreased 
ETT-related mucosal pressure ulcers. However, the frequency of ETT positioning to prevent 
mucosal pressure ulcers was not addressed in the study. Cooper (2013) noted that 
repositioning of ETT every 2 hours by the manufacturer’s recommendation was based on a 
patient turning schedule every 2 hours.  According to the PI’s personal communication with 
the manufacture of Anchor Fast’s clinical scientists, the every 2-hour repositioning of ETT by 
the manufacturer’s recommendation was not derived from evidence-based or a research-
based recommendation. Other authors suggest research is needed on how long any device can 
be in place before it needs to be moved or removed (Black et al., 2010; Norman, 2013).  
A study by Chun (2014) extracted data from the electronic medical record (EMR) 
during two different time periods: a) February 1, 2013 to March 9, 2013 (27 charts of 
intubated patients); and b) November 1, 2013 to December 9, 2013 (25 charts of intubated 
patients). However, a wide variability of prevalence rates was noted in June 2013 (15%) and 
December 2013 (0%). Findings showed higher usage of AnchorFast, fewer ventilator days, 
and improved nursing documentation about skin and oral care during November 1, 2013 to 
December 9, 2013. One patient developed OMPrU and used the ETT holder AnchorFast, but 
ETT repositioning was not done every 4 hours as per the QMC AnchorFast Guideline (see 
  9 
Appendix 1). A finding from this study concurred with Zaratkiewicz et al’s (2010) study, that 
the AnchorFast ETT holder decreased ETT-related OMPrUs; however, it also raises 
important questions about ETT repositioning frequency. Exploring and understanding 
microcirculation of upper lip oral mucosa related to securement and repositioning frequency 
in intubated patients will assist in the development of evidence-based practices designed to 
prevent ETT-related OMPrUs. 
Limitations of the Existing Literature 
 No research was found that examines labial mucosa microcirculation in the context of 
pressure ulcer development from ETTs.  A few studies (Cooper, 2013; Ozyurek & Yavuz, 
2015; Zaratkiewicz, 2012) suggest that using AnchorFast helped to reduce oral mucosa 
pressure ulcer related to ETT use, however the frequency of ETT repositioning was not 
addressed by these authors.   
Gaps in the Literature 
There is evidence suggesting a relationship between the use of AnchorFast and the 
prevention of oral mucosa pressure ulcer from ETTs.  However, no literature was found that 
examined the repositioning of ETTs on a sequential basis, such as every 2 hours, to prevent 
OMPrUs.   
Purpose Statement 
 The objective of this study was to explore the effects of ETT pressure and ETT 
repositioning frequency on oral mucosa microcirculation among intubated patients with the 
aim to guide clinicians in the prediction and prevention of OMPrUs. This knowledge may 
inform clinician’s knowledge in predicting and preventing OMPrUs.  
Theoretical Model / Conceptual Framework 
 According to Defloor (1999), both compressive force and shearing force have an 
impact on pressure ulcer development.  In his conceptual scheme model (Fig. 1), Defloor 
shows that these two factors affect tissue tolerance for pressure and oxygen that determine 
pressure ulcer development.  Defloor’s conceptual scheme is important in this study, as it can 
reveal both to what extent compressive force from ETT and shearing force from repositioning 
frequency of ETT changes in microcirculation of labial mucosa.  
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Figure 1. Defloor’s concept scheme.  From Defloor (1999).  Reprinted with permission. 
 
 
 
 Compressive force.  
 Defloor (1999) described compressive force as a force exerted perpendicularly to the 
tissue, while shear is a force exerted parallel to the tissue, and “a pressure higher than the 
capillary pressure would slow down the flow in the capillaries and lymph nodes, resulting in 
insufficient supply of oxygen and nutrients and insufficient evacuation of metabolic waste” 
(p. 208-209).  Intensity and duration of pressure from ETT would interfere flow in the 
capillaries, resulting in insufficient exchange of oxygen, nutrients and metabolic waste 
products.   
 Shearing force. 
 Defloor (1999) described shearing force as a force exerted parallel to the tissue, and 
this made perfect sense that shearing force from ETT repositioning could lead to stretching 
and micro-hemorrhaging from micro-trauma and possibly altering the papillary layer of the 
histology.    
 Tissue tolerance for pressure. 
 Defloor (1999) described tissue mass, age, dehydration, protein and vitamin C 
deficiency, corticosteroid, and stress would influence tissue tolerance. Nakagawa et al. (2011) 
studied age-related changes in the elastic properties and moisture content of the lower labial 
mucosa and found a negative correlation between age and distensibility of the lower labial 
mucosa and age and moisture content of the lower labial mucosa. This study supported that 
Defloor’s concept scheme of tissue tolerance for pressure as one of factors. Age and moisture 
of labial mucosa could change the resilience and capacity of the tissue to redistribute 
pressure.   
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 Tissue tolerance for oxygen. 
 Defloor (1999) stated that factors affecting oxygen supply such as fever, use of beta-
blockers, malnutrition, tobacco use, reactive hyperemia, diabetes, and hypotension could 
affect tissue tolerance for oxygen. Although there were several research studies of labial 
mucosa microcirculation with previously mentioned factors, it is too early of a stage to 
conclude that local mucosa microcirculation could be a measurement of systemic conditions.    
Chapter 2 Summary 
 Overall research on compressive and shearing forces from ETT affecting labia 
mucosa microcirculation is lacking.  Since this study’s aim is to describe changes of upper lip 
oral mucosa microcirculation related to ETT pressure and repositioning of ETT, Defloor’s 
conceptual model may be used to explain the phenomena under study. 
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Chapter 3. Methodology 
Purpose 
 The purpose of this study was to explore the effects of ETT pressure and repositioning 
frequency on oral mucosa microcirculation among intubated patients to guide clinicians in the 
prediction and prevention of OMPrU.  
Study Aim and Research Questions 
 Aim: Describe changes of upper lip oral mucosa microcirculation in relation to ETT 
pressure and repositioning.  
  Research Question 1. What microcirculation changes of upper lip oral mucosa 
occur from ETT pressure every 2 hours upon ETT repositioning during the first 8 hours of 
intubation using the ETT holder, AnchorFast.  
  Research Question 2. What relationships exist between participants’ vital 
signs (including body temperature, heart rate (HR), mean arterial pressure (MAP)) and oral 
mucosal microcirculation. 
  Research Question 3.  What relationship exists between participants’ age, 
SOFA score, and Braden Scale score and final 8-hour vital signs (including body 
temperature, heart rate (HR), mean arterial pressure (MAP)) and final 8-hour oral mucosal 
microcirculation.   
Research Design 
This study was a prospective, observational and descriptive, repeated measures design 
that compared the measurements of microcirculation variables of orally intubated patients 
using the AnchorFast securement of the ETT.  
Population and Participants 
Nine patients were recruited from a population of adult intubated patients at QMC 
MICU between January 7, 2016 to June 30, 2016. The sample were those patients admitted to 
the QMC MICU cared for by the MICU team care service. A convenience sample was used 
because of limited rental agreement period of  CytoCam. 
Inclusion and exclusion criteria. 
• Inclusion Criteria. Patients were eligible to participate in the study if they (or 
the legal authorized healthcare decision maker):  1) Were admitted or 
transferred to the QMC MICU between 4am to 3pm and were intubated less 
than 4 hours; 2) Were age 18 years old or greater; 3) Was able to be in a 
supine position with the head of the bed elevated at 30 degrees; 4) Was able to 
use the AnchorFast for ETT securement; 5) Could give informed consent (or 
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the legal authorized healthcare decision maker); 6) Were not required to have 
medicated ointment applied to their upper lip; 7) [the patient’s representative] 
was fluent in English; 8) Anticipated to be intubated longer than 12 hours; and 
9) received the MICU standard of care for ETT management (see Appendix C) 
and the QMC Ventilator Associated Pneumonia (VAP) / Ventilator Associated 
Event (VAE) bundle.  
• Exclusion Criteria. Patients were excluded from participation if they: 1) Were 
admitted or transferred to the QMC MICU between 3:01pm to 3:59am and 
intubated greater than 4 hours prior to QMC MICU;   2) Had a surgical 
intervention to the oral area such that RCP could not follow the QMC 
guideline for AnchorFast; 3) Had pressure ulcers, any wound, or trauma to 
upper lip prior to/upon admission; 4) Were required to have medicated 
ointment applied to their upper lip; 5) Were allergic to the water soluble lip 
moisturizer used by the MICU; 6) Required a bite block; 7) Was unable to 
give informed consent or had a legal authorized healthcare decision maker 
who would not provide informed consent; 8) [the patient’s representative] was 
not fluent in English; 9) Was anticipated to be intubated less than 8 hours; 10) 
Was going to procedures within first 8 hours of admission; 11) Was sitting up 
in chair within first 8 hours of admission; 12) Could not routinely be 
turned/repositioned every 2 hours; or 13) did not receive the MICU standard 
of care for ETT management (see Appendix C) and the QMC Ventilator 
Associated Pneumonia (VAP) / Ventilator Associated Event (VAE) bundle. 
Research Site 
This study took place at the QMC (Punchbowl) MICU, Honolulu, Hawai`i. This 
institution is a private, nonprofit, acute tertiary care facility with 535 acute and 40 sub-acute 
licensed beds. The MICU is an all-private room 19-bed unit with designated airborne 
isolation rooms, hemodialysis rooms, and an obstetrics and gynecology room. The unit 
operates on a 24-hour basis with 24-hour intensivist coverage. At the time this study took 
place, the average daily census was 14.8 patients. During the study period, the 19-bed MICU 
had an average 78% occupancy rate with an average 45 intubated patients per month and an 
average length of stay of 4.14 days. The MICU provides care for adults and adolescents over 
age 15. The most frequent diagnoses included patients presenting with status post ‘Code 
Blue’, respiratory failure, gastro-intestinal bleeding, diabetic emergencies, acute renal failure, 
sepsis/multi-system organ failure, and drug overdose.  
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As part of its day-to-day operations, the MICU also provides care to overflow 
surgical, neurosurgical, and cardiac ICU patients, as well as telemetry patients. It should be 
noted that all patients admitted to the QMC MICU must meet admission criteria per the QMC 
Critical Care Protocol and will have a point physician intensivist who has responsibility for 
coordinating and communicating the overall care of the patient. Upon admission, an MICU 
registered nurse (RN) initiates the nursing process for assessment, data collection, and care 
planning which includes the patient, his/her family and/or significant other in education 
needs, discharge planning needs, and ongoing clinical care.  
Operational Definitions 
• Microcirculation is defined as passage of blood in the smallest vessels, namely 
arterioles, capillaries, and venules (“microcirculation”, 2012). The CytoCam 
(see Appendix A) was used in this study to measure microcirculation of the 
inner aspects of upper lip mucosa and is described in terms of following 
variables:  
• Total Capillary Density (TCD; capillaries per millimeter squared [cpll/mm²]) 
is defined as the total number of all capillary loops present (regardless of its 
functional state) per visual field (Milstein et al., 2012) (see Figure 2). For the 
purposes of this study, this parameter was derived directly from three adjacent 
imaged clips from the designated region of interest (ROI), a mean from those 
three clips was used to represent the TCD of the targeted tissue site. The TCD 
count was taken on a frame size of 1.8 mm². The data for his parameter was 
quantified offline from the recorded files using Adobe Photoshop counting 
tool function.  
 
Figure 2. Lip mucosa TCD processing derived from CytoCam system 
 
• Functional Capillary Density (FDC; capillaries per millimeter 
squared [cpll/mm²]) is defined as the total number of functional 
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capillary loops present per visual field (Nolte et al., 1995; Milstein et 
al., 2012). Diffusion- and convection-based parameters are two main 
principles that describe how oxygen and blood reach the tissues from 
the microcirculation and define the main microcirculatory functional 
parameters obtained from microcirculatory images (Medina, Milstein 
& Ince, 2014). The FCD count was taken on a frame size of 1.8 mm². 
• Microcirculatory Flow Index (MFI; arbitrary units [AU]). This is the 
overall score computed for each selected vessel as described by 
Boerma et al. (Boerma et al., 2005). This is based on determination of 
the predominant flow type in each video sample using an ordinal scale 
consisting of either a score of 0 (no flow), 1 (intermittent flow), 2 
(sluggish flow), or 3 (continuous flow) in each of the four quadrants in 
the field of view of each imaged sample.  The MFI was assessed on a 
frame size of 1.8 mm².  
• Proportion of Perfused Capillaries (PPC; percentage [%]). This 
parameter is computed as a percentage and used to describe a ratio 
between perfused and non-perfused capillary loops in the ROI. 
Essentially this defines the amount of non-perfused versus the perfused 
capillary densities in the tissue of interest and can provide a way to 
quantitatively and describe mucosal perfusion level.  
• Blood Vessel Diameter (BVd; micrometer [µ]) is a parameter only 
available using the current gold standard software, AVA v3.02 
(MicroVision Medical BV, Amsterdam, The Netherlands). It requires 
selection of 20 vessels (at random) (Tytgat et al., 2013; Dirkes et al., 
2015) or more capillary loops to describe the potential changing 
morphologies of the capillary calibers in response to a stimulus (i.e. in 
this case ischemia from positioning of the ETT).   
• Oral mucosa is defined as the mucous membrane lining the cavity of 
the mouth, including the gums (“Oral mucosa”, 2012). It is “comprised 
of stratified squamous epithelium that overlies the lamina propria, 
which consists of fibroblasts and connective tissue, small blood vessels 
(capillaries), inflammatory cells (macrophages), and extracellular 
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matrix (ECM)” (Sonis, 2004) (see Figure 3). The upper lip mucosa in 
this study is the inner aspect of the lips and is not keratinized.   
  Figure 3. Oral Mucosa [from Sonis, 2004] 
 
• ETT pressure is defined as pressure on the upper lip mucosa against ETT 
while patient is intubated.  
• ETT reposition is defined as repositioning the ETT while it is secured with 
AnchorFast Oral ETT Fastener (see Figure 4). A special feature on 
AnchorFast allows changing the ETT position from side to side along the tube 
track.  
Figure 4. AnchorFast oral endotracheal tube fastener 
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  Research Question 2. What relationships exist between participants’ age, vital 
signs (including body temperature, heart rate (HR), mean arterial pressure (MAP), Sequential 
Organ Failure Assessment (SOFA) score, and Braden Scale score and oral mucosal 
microcirculation.   
  Definitions. 
• AnchorFast is a device to secure oral ETT and is manufactured by the 
Hollister Technology (see Appendix B).  
• SOFA score is defined as a mortality prediction score that is based on the 
degree of dysfunction of six organ systems (Kamal, 2015). The tool tracks a 
patient’s status during their ICU stay. The score is composed of sub-scores 
from 6 systems of the body (respiratory, cardiovascular, hepatic, coagulatory, 
renal, and neurological). Each system is graded from 0 to 4 points according to 
the degree of dysfunction:  The higher the score, the higher the dysfunction 
(see Appendix 4). The assignment of a score for each system is based on one 
or more variables. The SOFA score is a reliable outcome predictor (Ferreira, 
Bota, Bross, Melot, & Vincent, 2001), and the Primary Investigator (PI) has 
been trained to calculate the scoring for this study. SOFA score at the time of 
admission was used. Every third calculation was validated with the MICU 
intensivists.  
• BSPPSR - Braden Scale for Predicting Pressure Sore Risk is defined as a 
pressure ulcer development risk prediction score that is based on a patient’s 
sensory perception, skin moisture levels, activity, mobility, nutrition, friction, 
and shearing (see Appendix F). Scores range from 6 to 23. A score of 15-18 
indicates that the patient is at mild risk for developing a pressure ulcer; a score 
of 13-14 indicates moderate risk; a score of 10-12 indicates high risk; and a 
score of equal to or less than 9 indicates severe risk (Braden & Bergstrom, 
1988). Braden Scale score at the time of admission to MICU was used for this 
study. 
Sampling 
Recruitment plan  
Once the admitting MICU intensivist notified the charge RN of a potential admitted 
or transferred patient, the charge RN notified the Principal Investigator (PI) or the research 
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assistant RN for possible participant recruitment. The PI or research assistant RN obtained 
informed consent from the eligible participants or their designated decision maker/guardian.  
Power Analysis. The number of eligible participants that were enrolled and 
completed the study during the enrollment and data collection period determined the sample 
size (n=6).  For this analysis, if the variance was small and the effect size was 
‘medium’ (0.3), then for power of 0.9, the researched needed at least 22.  If the variance was 
large and the effect size was kept to medium, then the researcher needed sample size of 39 for 
power 0f 0.8.  The medium sample size was ‘conservative’ from the book based on non-
repeated measures. Therefore, depending on the effect size, the minimum sample size would 
be 20 which would get the researcher at least power of 0.8 or more for a medium effect size 
and alpha=.05.    
Measures 
The participant’s medical record number (MRN) and intubation date and time was 
collected from the EMR. This study utilized 9 instruments to collect the following data: Age, 
body temperature (T), heart rate (HR), blood pressure (systolic, diastolic and mean arterial), 
SOFA score, Braden Scale score, TCD, FCD, PPC, MFI and BVd. Participant age was age on 
admission to QMC. ICU routine vital signs (T, HR, BP) were taken hourly unless 
hemodynamically unstable.  
SOFA score. The SOFA instrument tracks a patient’s status during the stay in an ICU. 
The scoring system determines the extent of a person’s organ function or rate of failure. The 
score is composed of individual scores from six systems of the body (respiratory, 
cardiovascular, hepatic, coagulation, renal & neurological). Each of the 6 systems were 
graded from 0 to 4 points according to the degree of dysfunction; the higher the score, the 
higher the degree of dysfunction. The reliability and accuracy of SOFA scoring are 
considered “good” (Arts, Keizer, Vroom, & de Jonge, 2005), and several studies indicate that 
it is a useful predictor of patient outcome in critically ill patients (Ferreira, Bota, Bross, 
Melot, & Vincent, 2001; Vincent et al., 1998; Zygun, Berthiaume, Laupland, Kortbeek, & 
Doig, 2006).  
 BSPPSR.  The Braden Scale score includes 6 risk factors:  sensory perception, 
moisture, activity, mobility, nutrition, and friction and shear. Each factor is measured with a 
point scale, where a score of 1 means a high risk and 3 or 4 a low risk (Halfens & Van 
Achterber, 2000). At QMC, the total Braden Scale score of nine or below is very high risk, 
10-12 is high risk, 13-14 is moderate risk, 15-17 is low risk, and 18 or more is no risk. More 
than 11 published studies report the reliability of Braden Scale with inter-rater reliability 
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ranging from 0.83 to 0.99, with percent agreement ranging from 88% to 100% (Kring, 2007). 
The validity of the Braden Scale has sensitivity ranging from 61% to 100% at optimal Braden 
Scale cut-off points and specificity ranging 26% to 100% at optimal Braden Scale cut-off 
points; variations are based on the care setting and patient population (Kring, 2007). 
Microcirculation variables. Microcirculation variables such as TCD, FCD, PPC, MFI 
and BVd were measured using the CytoCam. This device is a non-invasive, incident dark-
field imaging (IDF) based (Sherman et al., 1971; Slaaf et al., 1987) handheld microscope 
(“CytoCam”, 2015). The device is a lightweight pen-like instrument with a length of 220 mm 
and diameter of 23 mm. It consists of a probe that incorporates stroboscopic green LED light 
(540 nm) illumination resulting in IDF illumination with a field of view of 1.55 x 1.16 mm 
(Aykut et al., 2015). “Combined with a set of high resolution lenses (magnification x4), it 
projects images onto a high-resolution computer-controlled image sensor” (“How it 
works/CytoCam-IDF”, 2015). The camera is connected to a medical grade panel PC, where 
the recorded images and analyses are stored. All data collected with the CytoCam conformed 
to the recommendations outlined by international consensus on microcirculation data 
acquisition and analysis (De Backer et al., 2007). The obtained parameters provide the 
following information: 1) How many capillaries are perfused, 2) What is the quality of the 
flow, and 3) Are there non-perfused areas next to well-perfused areas (Milstein et al., 2012; 
Weber et al., 2014; Aykut et al., 2014).  
Procedures 
Data Collection 
The study was conducted on patients admitted to QMC’s MICU who met inclusion 
criteria. Data was collected for 6 months (from January 7, 2016 to June 30, 2016). Upon 
receiving Institutional Review Board (IRB) approval, the MICU staff was oriented to the 
study. All patients received the MICU standard of care for ETT management (see Appendix 
C) and the QMC Ventilator Associated Pneumonia (VAP) / Ventilator Associated Event 
(VAE) bundle which included: 1) Elevating head of bed (HOB) ≥ 30 degrees, 2) Usage of Hi-
Lo Subglottic aspiration ETT, 3) Use of separate suction canisters for oral and endotracheal 
secretions, and 4) Providing oral care every 4 hours.  
After obtaining informed consent, data was collected from the participants’ EMR, 
including body temperature (T), mean arterial pressure (MAP), Braden Scale score, 
Sequential Organ Failure Assessment (SOFA) score, intubation date and time, and ETT 
repositioning date and time. Microcirculation variables such as TCD, FCD, PPC, MFI, and 
BVd were measured using the CytoCam. During microcirculation data collection, all 
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participants were in a supine position with HOB elevated for 15 minutes at a minimum of 
30°, with the ETT secured to the upper lip which is standard practice in the MICU. In the 
MICU, ETT are routinely maintained in a ‘neutral position’ as standard practice. An arm 
extends from the ventilator to hold the circuit that attaches to the ETT in such a way to 
prevent tugging action against to labial area. If additional support is required, a rolled towel is 
normally placed under the ETT to main a neutral position.  Microcirculation of the oral 
mucosa was measured using the CytoCam Video Microscope System (Braedius Medical, 
Huizen, The Netherlands). CytoCam images were used to collect both diffusion-related 
parameters (i.e. microvascular density such as TCD, FCD, and PPC; parameter indicative for 
oxygen distribution) and convection-related parameters (i.e. microvascular flow properties 
such as MFI and BVd) in accordance with international consensus on microcirculation data 
acquisition and analysis recommendations (De Backer et al., 2007).  It should be noted the 
time for repositioning of ETT in order to collect microcirculation data with the CytoCam was 
estimated to take approximately 11 seconds.  This includes approximately 1.25 ± .02 seconds 
for repositioning of the ETT (Fisher, Chenelle, Marchese, Kratohvil, and Kacmarek, 2014), 
plus 5 seconds to position the CytoCam probe on the region of interest (ROI), followed by an 
immediate capture of the video image which took 4 seconds.  The process was repeated 2 
additional times, adding 8 seconds, for a total capture of 3 videos. The total time to collect 
microcirculation data was estimated to take 11 seconds plus 8 seconds, or a total of 19 
seconds. If the participant’s head or mouth moved during this process, additional time must 
be taken into account and detailed description of additional time usage should be recorded for 
possible variabilities.  
Frequency of data collection. Data was collected from participants during the first 8 
hours from admitting in MICU. T, HR, SBP, DBP, MAP, and OM microcirculation variables 
(TCD, FCD, PPC, BVd, and MFI) were collected every 2 hours (Table 2; Appendix E). 
Management of collected data. All consents and data were stored in a locked 
research cabinet, and the CytoCam was locked in MICU nurse manager’s office when not in 
use. Only the PI, research assistant nurse and Dr. Scott Gallacher had access to the research 
data and the CytoCam. Off line data was available to Dr. Dan Milstein for verification.  
Measurements of Microcirculation of Upper Lip Oral Mucosa  
Locations of microcirculation of upper lip oral mucosa measurements are described in 
Figure 5. Microcirculation variables were measured in Area 1. Steady images of 4 seconds 
were acquired and stored. At each measurement point, the vital signs were collected. 
Microcirculation were measured as follows:   
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1. Measured Area 1’s TCD, FCD, PPC, MFI, and BVd as a baseline value (all data 
analysis was processed after acquisition). A straight line up from this area was 
marked on the AnchorFast track area with a blue marker and was named Area 
1. Area 1 and Area 2 were arbitrary locations to explain protocol procedures. 
Area 1 was identified as the lip area where no contact of ETT from initial 
intubation and Area 2 was identified as the lip area where ETT contacts upon 
initial intubation.  
2. Once obtaining Area 1’s baseline values of TCD, FDC, PPC, MFI and BVd, the 
ETT was placed on Area 1 for 2 hours (see Figure 3). The PI recorded the time 
of ETT repositioning. 
3. The PI checked the time of intubation in the participants’ EMR. Initial ETT 
interface area was named Area 2.  
4. After 2 hours from initial repositioning of the ETT (Area 2 to Area 1), the PI 
and Respiratory Care Practitioner (RCP) repositioned the ETT to Area 2.  
5. The PI measured Area 1’sTCD, FCD, PPC, MFI, and BVd immediately (within 
2 minutes).  
6. After measuring Area 1 at 2 hours, the PI and RCP repositioned the ETT back 
to Area 1. The ETT remained at Area 1 for another 2 hours. 
7. After 2 hours from step 6, the PI and RCP repositioned the ETT to Area 2. The 
PI measured Area 1’s TCD, FCD, PPC, MFI, and BVd immediately (within 2 
min) after re-positioning the ETT to Area 2. Area 3 was considered the ETT 
free area during measurement of Area 1 and 2’s microcirculation variables. 
8. After measuring Area 1 at the 4-hour mark, the ETT was repositioned back to 
Area 2 and remained in Area 2. This complies with current QMC AnchorFast 
guideline that the ETT is repositioned after 4 hours in one place.  
9. After 2 hours from no contact of the ETT in Area 1, the PI measured Area 1’s 
TCD, FCD, PPC, MFI, and BVd. This step was to assess if Area 1 had possible 
reperfusion ischemia or injury 2 hours free of the ETT contact.  
10. After 4 hours from no contact of the ETT in Area 1, the PI measured Area 1’s 
TCD, FCD, PPC, MFI, and BVd. This step was to assess if Area 1 had possible 
reperfusion ischemia or injury 4 hours free of the ETT contact.  
11. The PI and nursing staff continued care using the current QMC AnchorFast 
guideline. 
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Figure 5. Locations of microcirculation measurements  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Area 2:  Initial 
ETT interface 
area.  Area 1:  
Intervention 
site 
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Table 2. Summary of data collection procedure 
Data 
Collection 
Time 
Location of 
Measurement 
ETT 
Location 
during 
Data 
Collection 
ETT 
Location 
immediately 
after Data 
Collection 
CC 
Variables 
EMR 
Variables 
Upon 
recruitment 
Area 1 Area 2 Area 1 TCD, 
FCD, PPC, 
MFI, BVd 
T, HR, SBP, 
DBP, MAP, 
SOFA score, 
Braden Scale 
score 
After obtaining baseline measurements of Area 1, repositioned the ETT from Area 2 to 
Area 1. 
2-hours 
after 
reposition 
Area 1 Area 2 Area 1 TCD, 
FCD, PPC, 
MFI, BVd 
T, HR, SBP, 
DBP, MAP 
4-hours 
after 
reposition 
Area 1 Area 2 Area 2 TCD, 
FCD, PPC, 
MFI, BVd 
T, HR, SBP, 
DBP, MAP 
2-hours 
after 
reposition 
Area 1 Area 2 Area 2 TCD, 
FCD, PPC, 
MFI, BVd 
T, HR, SBP, 
DBP, MAP 
4-hours 
after 
reposition 
Area 1 Area 2 Area 2 TCD, 
FCD, PPC, 
MFI, BVd 
T, HR, SBP, 
DBP, MAP 
 
Assurances of Interrater Reliability  
 The intraclass correlation coefficient (ICC) was used for the analysis of the interrater 
reliability test.  A high degree of reliability was found between PI’s and expert’s TCD 
measurements.  The single measure ICC was .974 with a 95% confidence interval from .826 
to .996 (F (5,5) = 74.771, p=.000). A high degree of reliability was found between PI’s and 
expert’s FCD measurements.  The single measure ICC was .970 with a 95% confidence 
interval from .801 to .996 (F (5,5) = 64.807, p=.000).   
Data Management 
 To prevent inadvertent re-enrollment, the enrolled patient’s name and medical record 
number (MRN) were recorded on a paper data record book during recruitment and stored in 
the binder. Data was entered into and stored on the researcher’s personal, password-protected 
computer with only the assigned numeric codes to de-identify data and enhance 
confidentiality. The binder, along with all participant data was collected and saved on a USB 
flash drive (Kingston Data Traveler Locker+G2) that has built-in encrypted capability and 
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was stored in a locked file cabinet in the MICU nurse manager’s office. The PI did not save 
any data on the hard drive of the project’s password-protected laptop.  
Human subjects  
Informed consent. 
This proposal was submitted to the QMC IRB and the University of Hawai`i IRB. 
Prior to study enrollment, informed consent was obtained from each participant or their 
decision makers by the PI or research assistant RN at QMC. 
 Anonymity/confidentiality. 
 All personal information was de-identified before data entry.  Results of this research 
was only presented as grouped data.   
 Penalty for non-participation/withdrawal or preferential treatment for 
participation.   
 Participants had the option to withdraw from the study at any time for any reason.  
Participants were allowed to withdraw or decline participation without any interference of 
care the participant received at the time of the study or in the future. There was no 
preferential treatment for participation.   
Risks and benefits 
 Risks. Using non-invasive technology to measure microcirculation of upper lip oral 
mucosa for short period of time (4 seconds per study sites) has minimal risks to participants. 
Previous studies indicated was no risk or side effects using CytoCam (IDF technology).  
 Benefits. Findings from this study will help clinicians understand more about upper 
lip oral mucosa microcirculation changes in intubated patients and the benefits of 
repositioning of ETT to prevent ETT related OMPrUs.   
 Data and safety monitoring plan. 
 Adverse event (AE) reporting.  No AE occurred.  If there was an AE, the researcher 
was going to reported to the IRB and Medical Director of MICU, and the study halted during 
investigation of the event. 
 Risk minimization. 
 The risk of causing pain during data acquisition was minimized in two ways: 
• During the data acquisition, patients were reassured that data acquisition was 
done by lightly touching the inner upper lip. 
• If patients were experienced excruciating pain, the data acquisition would not 
continue.   
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 Study termination, early withdrawal of individuals. 
 Participants had the option to withdraw from the study at any time for any reason.   
 Confidentiality. 
 All of the participants’ information was de-identified before data entry. 
 Data Security. 
 Participant information/demographics was known only to the researcher. Vital signs 
were shared information among MICU nurses, doctors, and consultants for medical treatment 
and intervention. Oral mucosa microcirculation information was only shared with Dr. 
Milstein for expertise. Participants information was only obtained during IRB approved 
period.   
Record retention. 
 The researcher will retain copies of the data in secure file for the length required by 
the IRB. 
Chapter 3 Summary 
Many patients admitted to critical care units already have compromised systemic 
microcirculation due to sepsis, diabetes, and cardiovascular diseases (Weber et al, 2014). 
Direct pressure by medical devices is known to cause mucosal pressure ulcers, and intubated 
patients in critical care units have additional risk to develop OMPrUs from ETT.  A 
prospective, descriptive, repeated measures design was used to compare the measurements of 
microcirculation variables of orally intubated patients using the AnchorFast securement of 
the ETT. 
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Chapter 4. Statistical Analysis 
 Descriptive statistics, Nonparametric one-way ANOVA with repeated measures 
(Friedman Test) and Spearman’s correlations were used. If statistically significant differences 
were found with the ANOVA, then pairwise multiple comparison tests were used to find 
where the differences occur. The level of significance was 0.05 for all analyses All statistical 
analyses were performed in SAS version 9.4 (SAS Institute, Cary, NC).  
Sample 
 Two hundred intubated patients were under the care of QMC MICU at the time of 
data collection (January 7, 2016 to June 30, 2016). 72 patients out of 200 patients were 
admitted between 4am and 3pm.   Ten patients were eligible for recruitment.  Of those 10 
patients, 1 patient declined to participate in the study. Nine patients provided consent, 1 
patient’s condition became severely deteriorated within 2 hours of recruitment and was not 
able to obtain data longer.  Additional 2 participants’ data was omitted from data analysis: 1 
patient was coughing constantly during data collection and was not able to assess accurate 
capillary counts and flow upon completion of all data collection; 1 patient’s video clip 
background was too bright to assess measurements.  Analysis herein is based upon the 
remaining 6 participants. Data were collected on QMC MICU only.  
Participants’ Demographic and Clinical Characteristics 
 The mean age of participants was 54 years old (range 32-71) (±14 SD), the mean HR 
was 95 (±20 SD) beats per minutes (bpm), the mean SBP was 96 bpm (±16 SD), the mean 
DBP was 64 bpm (±6 SD), the mean SOFA score was 12 (±2 SD) and the mean Braden Scale 
score was 14 (±2 SD).  Three out of six participants (50%) were on anticoagulant 
(Enoxaparin sodium) and vasopressor (Norepinephrine).  
Table 3. Demographic and clinical characteristics (N=6) 
Variable N 
Lower 
Quartile Median 
Upper 
Quartile Mean ± SD 
ETT size 
Age (years) 
HR (bpm) 
SBP (mmHg) 
DBP (mmHg) 
SOFA score 
Braden Scale score 
6 
6 
6 
6 
6 
6 
6 
8.00 
44.00 
81.00 
85.00 
61.00 
10.00 
13.00 
8.00 
56.50 
96.50 
96.50 
65.00 
13.00 
13.50 
8.00 
64.00 
100.00 
109.00 
66.00 
14.00 
14.00 
8.00 
54.00 
95.00 
95.67 
64.33 
12.17 
13.50 
0 
14.32 
19.69 
16.22 
5.65 
2.23 
2.26 
 
 The mean body temperature of participants at baseline was 36.8 ℃ (±0.8 SD), 37.4℃ 
(±0.8 SD), 37.5℃ (±0.3 SD), 37.6℃ (±0.5 SD), and 37.7℃ (±0.9 SD) over the 8 hours 
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period. The mean heart rate of participants at the baseline was 95 bpm (±20 SD), 89 bpm 
(±13 SD), 89 bpm (±14 SD), 88 bpm (±16 SD), and 92 bpm (±15 SD) over the 8-hour period. 
The mean MAP of participants at the baseline was 75 mmHg (±7 SD), 77mmHg (±8 SD), 80 
mmHg (±15 SD), 79 mmHg (±4 SD), and 77 mmHg (±7 SD) over the 8-hour period. The 
mean SBP/DBP at the baseline was 96/64 mmHg (±16/6 SD), 105/65 mmHg (±15/7 SD), 
109/67 mmHg (±11/19 SD), 104/67 mmHg (±15/10 SD), and 104/65 mmHg (±16/8 SD) over 
the 8-hour period. 
Table 4. Temperature, heart rate (HR), mean arterial pressure (MAP), systolic blood pressure 
(SBP), diastolic blood pressure (DBP)  
Variable N Median Mean ± SD 
Baseline T (℃) 
+2 hour T 
+4 hour T 
+6 hour T 
+8 hour T 
Baseline HR (bpm) 
+2 hour HR 
+4 hour HR 
+6 hour HR 
+8 hour HR 
Baseline MAP 
(mmHg) 
+2 hour MAP 
+4 hour MAP 
+6 hour MAP 
+8 hour MAP 
6 
6 
5 
3 
5 
6 
6 
5 
4 
6 
6 
6 
5 
4 
6 
6 
 
37.00 
37.55 
37.50 
37.80 
37.40 
96.50 
91.00 
95.00 
87.00 
93.50 
74.00 
75.50 
75.00 
80.00 
76.50 
96.50 
 
36.82 
37.43 
37.50 
37.57 
37.74 
95.00 
88.83 
88.60 
87.75 
91.67 
74.83 
77.00 
79.60 
78.50 
76.83 
95.67 
 
0.79 
0.80 
0.33 
0.49 
0.89 
19.69 
13.23 
14.29 
15.54 
14.26 
6.91 
7.54 
15.34 
3.79 
7.14 
16.23 
   
Research Question 1.  
 What microcirculation changes of upper lip oral mucosa occur from ETT pressure 
every 2 hours upon ETT repositioning during the first 8 hours of intubation using the ETT 
holder, AnchorFast?  Descriptive statistics analyzed median, range, mean and standard 
deviation (SD) of upper inner lip mucosa (labial) microcirculation variables for 5 levels of 
time:  baseline, 2 hours, 4 hours, 6 hours and 8 hours.  Friedman’s Test was used to analyze 
upper inner lip mucosa (labial) microcirculation variables due to very small sample size 
(n=6). The level of significance was 0.05. 
 The mean TCD at the baseline was 69.34 (±19.53 SD), 59.84 (±17.6 SD) at 2 hours, 
57.34 (±18.14 SD) at 4 hours, 61.17 (± 20.92 SD) at 6 hours, and 65.34 (±21.38 SD) at 8 
hours (Table 5).   
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Table 5. Total capillary density (TCD) capillaries per 1.8 millimeter squared [cpll/mm²] 
Variable N Median Mean ± SD 
Baseline TCD 
+2 hours TCD 
+4 hours TCD 
+6 hours TCD 
+8 hours TCD 
6 
6 
6 
6 
6 
69.34 
59.84 
57.34 
61.17 
65.34 
67.83 
59.22 
60.45 
58.95 
63.00 
19.53 
17.6 
18.14 
20.92 
21.38 
 
 The mean FCD at the baseline was 65.84 (± 20.76 SD), 52.17 (±16.47 SD) at 2 hours, 
49.34 (±17.42 SD) at 4 hours, 58.67 (± 20.96 SD) at 6 hours, and 60.84 (± 21.62SD) at 8 
hours (Table 6).  
Table 6. Functional capillary density (FCD) capillaries per 1.8 millimeter squared [cpll/mm²] 
Variable N Median Mean ± SD 
Baseline FCD 
+2 hours FCD 
+4 hours FCD 
+6 hours FCD 
+8 hours FCD 
6 
6 
6 
6 
6 
65.84 
52.17 
49.34 
58.67 
60.84 
64.78 
55.17 
55.67 
56.28 
59.39 
20.76 
16.47 
17.42 
20.96 
21.62 
 
 The mean PPC at the baseline was 96.23 (±5.91 SD), 93.09 (±5.78 SD) at 2 hours, 
91.83(±7.19 SD) at 4 hours, 96.46 (±4.47 SD) at 6 hours, and 93.56 (±4.74 SD) at 8 hours 
(Table 7). 
Table 7. Proportion of perfused capillaries (PPC) % 
Variable N Median Mean ± SD 
Baseline PPC 
+2 hours PPC 
+4 hours PPC 
+6 hours PPC 
+8 hours PPC 
6 
6 
6 
6 
6 
96.23 
93.09 
91.83 
96.46 
93.56 
94.89 
93.56 
91.03 
94.77 
93.65 
5.91 
5.78 
7.19 
4.47 
4.74 
 
 The mean MFI at the baseline was 2.84 (±0.39 SD), 2.84 (±0.39 SD) at 2 hours, 3 
(±0.17 SD) at 4 hours, 3 (±0.4 SD) at 6 hours, and 3 (±0.4 SD) at 8 hours (Table 8). 
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Table 8. Microvascular flow index (MFI) 
Variable N Median Mean ± SD 
Baseline MFI 
+2 hours MFI 
+4 hours MFI 
+6 hours MFI 
+8 hours MFI 
6 
6 
6 
6 
6 
2.84 
2.84 
3 
3 
3 
2.72 
2.72 
2.89 
2.78 
2.78 
0.39 
0.39 
0.17 
0.4 
0.4 
 
 Comparison of the repeated measures (oral mucosa microcirculation) was performed 
using Friedman’s test showing a difference between baseline, 2-hour ETT position, 4-hour 
ETT position, 2- hour free of ETT and 4-hour free of ETT using alpha = 0.05. TCD 
(Friedman’s Test Q = 4.13, df = 4, p=0.39), FCD (Friedman’s Test Q = 4.81, df = 4, p=0.31), 
PPC (Friedman’s Test Q = 2.32, df = 4, p=0.68) and MFI (Friedman’s Test Q = 4.88, df = 4, 
p=0.3) were not statistically significant over all.   As shown in Figures 6, 7, 8, and 9, the 
mean and median level of TCD, FCD, PPC, and MFI at all 5 time points (baseline, 2 hours, 4 
hours, 6 hours, and 8 hours) were similar.   
Figure 6. TCD mean and median over 8 hours (X mark = mean) 
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Figure 7. FCD mean and median over 8 hours (X mark = mean) 
 
Figure 8. PPC mean and median over 8 hours (X mark = mean) 
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Figure 9. MFI mean and median over 8 hours (X mark = mean) 
 
 There was no significant difference of TCD, FCD, PPI, and MFI at 2-hours and 4-
hours mark by Wilcoxon tests (see Figures 10, 11, 12, and 13). 
Figure 10. Distribution of Wilcoxon scores for TCD 
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Figure 11. Distribution of Wilcoxon scores of FCD 
 
Figure 12. Distribution of Wilcoxon scores of PPI 
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Figure 13. Distribution of Wilcoxon scores of MFI 
 
Summary of Research Question 1 
 The mean level across 5 time points had no statistically significant difference for 
TCD, FCD, PPC and MFI, all p>27.  Comparing 2-hour and 4-hour points’ TCD, FCD, PPC, 
and MFI reported no significant difference, p>0.57.  There was high positive correlation 
between TCD and FCD (spearman rho > 0.9). 
Research Question 2.  
What relationships exist between participants’ vital signs (including body 
temperature, heart rate (HR), mean arterial pressure (MAP)) and oral mucosal 
microcirculation? Descriptive statistics analyzed median, range, mean and standard deviation 
(SD) of vital signs for 5 levels of time:  baseline, 2 hours, 4 hours, 6 hours and 8 hours. 
Relationships between vital signs and oral mucosal microcirculation variables were examined 
via the Spearman correlation coefficient. The level of significance was 0.05. 
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Table 8. Correlation between Vital Signs, Baseline  
Mean HR T MAP 
FCD -0.49 
0.33 
-0.81 
0.05 
0.37 
0.47 
TCD -0.49 
0.33 
-0.81 
0.05 
0.37 
0.47 
PPC -0.75 
0.08 
-0.57 
0.23 
0.09 
0.87 
MFI 0 
1 
0.31 
0.55 
-0.18 
0.73 
 
Table 9. Correlation between Vital Signs, at 2 hours 
 
Mean HR T MAP 
FCD -0.6 
0.21 
0.14 
0.78 
0.72 
0.10 
TCD -0.60 
0.21 
0.14 
0.78 
0.72 
0.10 
PPC 0.38 
0.46 
-0.06 
0.91 
-0.43 
0.4 
MFI -0.37 
0.47 
0.33 
0.52 
0.03 
0.95 
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Table 10. Correlation between Vital Signs, +4 hours 
Mean HR T MAP 
FCD -0.66 
0.15 
0.82 
0.26 
0.83 
-0.31 
TCD -0.75 
0.08 
-0.17 
0.74 
-0.14 
0.79 
PPC 0.37 
0.46 
0.26 
0.61 
-0.31 
0.54 
MFI 0.31 
0.54 
0.1 
0.84 
-0.21 
0.69 
 
Table 11. Correlation between vital signs, +6 hours 
Mean HR T MAP 
FCD -0.64 
0.17 
0.14 
0.79 
-0.06 
0.91 
TCD -0.64 
0.17 
0.14 
0.79 
-0.06 
0.91 
PPC -0.06 
0.91 
-0.25 
0.62 
0.32 
0.54 
MFI -0.31 
0.55 
0.34 
0.51 
-0.77 
0.07 
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Table 12. Correlation between Vital Signs +8 hours 
Mean HR T MAP 
FCD -0.37 
0.47 
0.37 
0.47 
0.31 
0.54 
TCD -0.49 
0.33 
0.14 
0.79 
0.26 
0.62 
PPC 0.26 
0.62 
0.77 
0.07 
-0.14 
0.79 
MFI 0.44 
0.38 
0.17 
0.74 
-0.85 
0.03 
 
Summary of Research Question 2 
 Based on the results of the study, there was a statistically significant negative 
relationship between body temperature and TCD and FCD only, r= -0.82, p = 0.05.  Also, 
there was a statistically significant negative relationship between MAP and MFI at 8-hour 
time point, r = -.85, p = 0.03.  However, there was no statistically relationship between 
temperature, HR, MAP and TCD, FCD, PPC and MFI at 2, 4, 6-hour time points. 
 Research Question 3.  What relationships exists between participants’ age, SOFA score, 
and BSPS and final 8-hour time period for vital signs (including T, HR, MAP) and final 8-
hour oral mucosal microcirculation?  Relationships between age, SOFA score, BSPPSR, final 
8-hour VS and final 8-hour oral mucosal microcirculation variables were examined via 
Spearman correlation coefficient. The level of significance was 0.05. 
 
Table 13. Correlation between age, BSPPSR, and SOFA 
 
 
 
 
 
 
 
  Age Braden SOFA 
TCD 0.37 -0.77 0.03 
0.47 0.08 0.95 
FCD 0.31 -0.85 -0.03 
0.54 0.03 0.95 
PPC 0.6 -0.5 0.21 
0.21 0.31 0.69 
MFI 0.44 0.68 -0.11 
0.38 0.14 0.84 
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Summary of Research Question 3 
 There was a statistically significant negative relationship between BSPPSR and TCD 
or FCD between subjects, p < 0.05.  Because there were only baseline BSPPSR collected, 
within-subject BSPPSR association over time was not assessed.   
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Chapter 5. Discussion 
 MDRPUs are a new challenge for healthcare teams caring for critically ill patients in 
addition to preventing traditional pressure ulcers because medical devices are a necessity for 
these patients.  Among MDRPUs, ETT related OMPrUs have the highest percentage of 
occurrence, yet there is no research specific to oral mucosa microcirculation changes related 
to ETT compressive force and shearing. Few studies found that using AnchorFast caused 
lesser OMPrUs, however the recommendation of ETT repositioning every 2 hours by the 
manufacture was based on patient turning schedules. Thus, it is essential to gain a better 
understanding of the oral mucosa microcirculation in the context of ETT related pressure 
ulcer prevention, and further research can help guide healthcare team members in more 
reliable evidence-based practices to promote safer care.   
 The purpose of this study was to explore the effects of ETT pressure and ETT 
repositioning frequency on oral mucosa microcirculation among intubated patients, it is 
anticipated that inspection and quantification of the oral mucosa microcirculation could guide 
clinicians towards the prediction and prevention of OMPrUs. Once approved by QMC’s IRB 
and the University of Hawai`i’s Human Subjects Committee, QMC MICU patients meeting 
the inclusion criteria were recruited and participated in the study over 6-month period.  A 
convenience sample of data from 8 participants was completed. While maintaining patient 
confidentiality, the data was described, analyzed and reported in order to explore oral mucosa 
microcirculation related to ETT pressure and ETT repositioning frequency among intubated 
patients.   
Interpretation of Findings 
 Correlation between oral microcirculation variables and compressing hours for 
OM by ETT 
 The results of 6 participants’ upper lip mucosa microcirculation variables measured at 
2-hour intervals (for a total of 8 hours) are presented in Tables 3, 4, 5, 6, and 7.  The TCD 
trend minimally decreased after 2 hours of intubation and continuously decreased even after 2 
hours of no ETT period. TCD increased closer to baseline after 4 hours of no ETT.   The 
trend of FCD was more fluctuating during 8 hours of observation.  The FCD trend was down 
the most after 2 hours of ETT compressing oral mucosa, but increased FCD trend noted 2 
hours of no compressing oral mucosa (measured site after 4 hours of compressing oral 
mucosa and 2 hours of no compression oral mucosa).  FCD decreased again even after 4 
hours of no compressing oral mucosa. According to Tsai et al. (1995), “changes in FCD 
reflect mechanisms that modulate the entrance of red blood cells into the capillaries PPC 
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results were very similar pattern to FCD.  These mechanisms have anatomical origin, 
whereby the capillary diameter changes, and may also be hydrodynamic, when flow 
conditions prevent red blood cells from entering a capillary branch” (p. 238). These results 
correlated with trend of PPC as well.  The MFI remained the same overall.  In theory, when 
no pressure exerted on the mucosa through ETT placement, MFI would climb towards 
normal perfusion if it indeed was compromised and scored less than 2.  gradually decreased 
over 6 hours of intubation but improved after 4 hours of no compressing oral mucosa. 
Compressive force, shearing force, and patients’ intrinsic variables affected oral mucosa 
microcirculation related to ETT.   
 By conducting exploratory analysis, there was high correlation between TCD and 
FCD illustrated by fitted non-parametric LOESS smooth curve.  As shown in Figure 14, each 
individual’s TCD and FCD association and 30 data-point TCD and FCD association had 
similar positive linear pattern. 
Figure 14. High correlation between TCD and FCD (r = 0.987, p < 0.0001, n=30) 
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Figure 15. Participants’ individual TCD and FCD correlation (r = 0.942, p = 0.0048, n=6 at 
end point) 
 
Correlation between Oral Mucosal Microcirculation Variables and Vital Signs and 
SOFA Score  
 The study results showed that MFI and MAP were positively correlated and 
statistically significant.  Improved MAP increased systemic blood flow that might affect MFI.  
However, the relationship between pressor (norepinephrine) and anticoagulant (enoxaparin 
sodium) and oral mucosa microcirculation variables was not found to be statistically 
significant. Studying certain regions of oral mucosa delivers vital information about 
particular region of oral mucosa’s pathological lesions for its diagnostic purpose (Milstein, 
2015, email correspondence).  Need of more robust results of oral mucosa microcirculation is 
essential to find correlation with certain disease progress and diagnoses.  There was no 
relationship observed between oral mucosal microcirculation variables and SOFA Score. 
Trzeciak et al. (2008) found that a decreased SOFA score (a lower SOFA score indicates a 
less patient acuity) had significant positive change in microcirculatory flow index (MFI).  
However, this was observed in sublingual microcirculation network, no capillary loops and 
not in labial mucosa.  Although papillary layer capillary loops are connected to their 
underlying nutritive microcirculation network in the reticular layer, MFI assessment may 
manifest differently as advancing one level more superficially towards the sub-epithelium. 
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There was a trend of TCD and FCD dropped at certain temperature point (see Figures 16 & 
17), HR (see Figures 18, 19), and MAP (see Figures 20,21). 
Figure 16. Fitted non-parametric LOESS smooth curve of TCD and T 
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Figure 17. Fitted non-parametric LOESS smooth curve of FCD and T 
 
 
 
Figure 18.  Fitted non-parametric LOESS smooth curve of TCD and HR 
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Figure 19. Fitted non-parametric LOESS smooth curve of FCD and HR 
 
Figure 20. Fitted non-parametric LOESS smooth curve of TCD and MAP 
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Figure 21.  Fitted non-parametric LOESS smooth curve of FCD and MAP 
 
 This study did not record the presence/non-presence of a heated wire ventilator circuit 
which is embedded in some of the ventilators used in the MICU depending on the patient’s 
condition. Heated wires circuit is used to ensure optimal humidification of the oxygen. It is 
noted that a heated wire may affect the temperature of the ROI. 
Correlation between Oral Mucosal Microcirculation and BSPPSR 
 The baseline correlation of oral mucosal microcirculation and BSPPSR had 
unexpected results.  Since higher the BSPPSR means healthier individuals, positive 
correlation was expected.  However, this study results were shown negative correlation.  
Because this study used BSPPSR measured only at baseline, changes in the BSPPSR were 
not captured if the participant’s condition changed over time. For example, if the participant 
was started on sedatives after the baseline score was assessed, the BSPPSR would not reflect 
potential changes in the score. In addition, the BSPPSR is designed to measure systemic 
issues such as sensory perception, degree to which skin is exposed to moisture, patient 
activity, mobility, friction and shearing, and nutrition, while this study focused on the 
investigation of the non-systemic local oral mucosa microcirculation. Finally, the study did 
not include the collection of specific sedatives given to the participants which could have 
affected the BSPPSR cognition subscale, which could be included in future studies.  
Individuals’ alteration of alertness/cognition may cause higher or lower exerted pressure from 
individuals’ behaviors such as biting ETT, moving head, trying to sit upright, trying to get out 
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of bed, or attempting extubation. Future research studies should include subscale of BSPPSR 
especially for critically ill patients.   
Study Strengths 
 There is inadequate evidence to prevent ETT related OMPrUs.  This study adds to the 
body of knowledge with regard to the oral mucosa microcirculation and how ETT 
compressive and shearing force alters oral mucosa microcirculation.  Using the IDF imaging 
device compared to video-capillaryscopy and laser doppler, it provided better visualization of 
the microcirculation at capillary level.   
 The continuous measurement of the oral mucosa at repeated 2-hour time points up to 
8 hours strengthen the study design using a participant’s baseline data as control. 
Study Limitations 
 A number of limitations must be acknowledged:  
Assumptions regarding the connection between microcirculation and tortuosity of 
capillaries and participants’ medical diagnoses were not validated in this study.  Increased 
capillary density and tortuosity were associated in patients with diabetes according to the 
presence of coronary artery disease (Djaberi et al., 2012).   
 Isolating the pressure and shearing force of ETT that cause alteration of oral mucosa 
microcirculation in critically ill was not achievable. The influence of external factors on 
capillary recruitment was limited by standardizing the study environment such as the room 
temperature, degree of ETT and participants’ upper lip, and room light source.  Also, flow 
alteration in the microcirculation due to the data collector was minimized yet it can be 
assumed there was some pressure during acquisition of images.  
 The small sample size is another study limitation.  Due to financial constrictions, the 
CytoCam was only available to the study investigators for six months.  During the data 
collection period, an unusually lower number of intubated patients.  The MICU admitted 
more patients on non-invasive respiratory support devices as a result of another advanced 
care planning project in the same MICU.    
 A longer training period of data collection and manipulation of the CytoCam should 
be considered to obtain improved image acquisition and interpretation of collected data. 
Understanding of flow index measurement is important that “the MFI score differentiates 
between the different types of continuous flows…. MFI should be preferred in more 
homogenous conditions because it takes into account the difference between sluggish and 
continuous flows” (De Backer et al., 2007).   
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 The pressure exerted on the ROI during microcirculation data collection with the 
CytoCam probe was a limitation because it may cause a reactive hyperemia, or the transient 
increased in blood flow following brief period of ischemia.  
 It is difficult to apply these findings to the longer term intubated ICU patient, due to 
the limited 8-hour oral mucosal measurement timeframe used in this study.  For example, 
patients who are intubated for a great time may not have the same outcome of no OMPrU 
found in this study sample. 
This study was conducted using a convenience sample within a single ICU setting. 
Further restriction of data collection time occurred because of the ICU sleep program for the 
patients at nights.   
Implications for Nursing Practice 
  Although endotracheal tube holders help prevent ETT related OMPrU, repositioning 
of ETT every 2 hours due to traditional every 2-hour turning schedule raised a question about 
repositioning every 2 hours would prevent OMPrU related to ETT.  This study’s results 
supported the current MICU OMPrU prevalence rate of zero for last four prevalence surveys 
with every 4 hours of repositioning of ETT with ETT neutral position. 
 Movement of evidence-based practice and research-based practice in nursing raise the 
bar for standards of nursing care. However, guidelines and recommendation of paucity of 
research studies can hinder patient safety and nursing workloads. Nurses need to make efforts 
to find evidences to develop standards of care and guidelines. Rigorous nursing research 
studies and findings make an impact to deliver safe care and break the habit of “this-is-how-
we-used-to-do”.  
 Recommendations for Future Research  
 Researchers have identified further systematic investigation is needed to determine 
how long any device can be in place before it needs to be moved or removed and how often 
to examine the skin (Black et al., 2010), and this study was the first step closer to researchers’ 
recommendation.   Since it was feasible to conduct this study in the MICU, it is anticipated 
that a larger number of participants may give us more robust results with a longer period of 
time especially if it was uncertain how long it would take the OM microcirculation to return 
to baseline values without pressure of friction and shearing for 2 hours and 4 hours.   
 Adequate and sufficient amount of time to train for measurements with the CytoCam 
is beneficial for achieving reliable and accurate data.  Future study should consider more 
consistent environmental factors such as room temperature, room brightness, and degree of 
ETT to oral mucosa.  Multidisciplinary research study should consider to exam other possible 
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variables that contribute OMPrU such as proper application of Anchor Fast, Anchor Fast with 
a built-in bite block, correlation with arterial blood gas and compliance of ETT neutral 
position.  There is a need to increase the frequency and duration of the oral mucosal 
measurements because more data is needed to substantiate the capillary refill times due 
to physiological phenomenon, e.g., reactive hyperemia.  
Conclusion 
 The assessment of oral mucosa, in this case labial mucosa, quantifying 
microcirculation was feasible and reproducible using the IDF imaging device for the purpose 
of research, yet it is noted that an adequate amount of training and understanding of 
interpretation of each microcirculation variable yields better experimental design and reliable 
scientific results. It should be noted that the procedures outlined in this research and the use 
of CytoCam device in an ICU’s standard practice would be challenging not only because of 
the specialized training required to operate the CytoCam, but especially due to the specialized 
training needed to properly understand and interpret the measurement data.  
None of the 6 participants developed OMPrU(s) from ETT and had no clinically and 
statistically significant changes of their microcirculation when repositioning ETT, while 
maintaining a neutral ETT position, every 2 hours versus every 4 hours. These research 
results provide a foundation of data to support such a change in future nursing practice. More 
research is needed to create enough evidence to support repositioning every 4 hours a 
standard practice in the MICU.   
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Appendix A 
CytoCam 
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Appendix B 
AnchorFast 
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Appendix C 
Guidelines for use of the AnchorFast Oral Endotracheal Tube (ET) Fastener at QMC 
Guidelines for use of the Anchor Fast Oral Endotracheal Tube (ET) Fastener: 
Indications for use:  
• Use on patients requiring intubation for longer than 24 hours only • Use on adults with an 
ET tube 5-10 cm in size 
• Confirm suitability:  
--requires maxillary support --has intact upper teeth 
--no protruding teeth 
--no facial edema  
• Special considerations: 
--has facial hair that impedes the ability to secure the device --inability to remove facial hair 
--may need to use oral airway to prevent biting down on ET  
Prepare the skin and apply the fastener:  
• Skin should be clean dry and free of oils  Do not use skin preps  
 Remove liners from the two skin barriers on device 
 Center the device gently on the upper lip with the foam bumper touching the skin 
(do not  
apply pressure)  
• Clamping mechanism should be about 1⁄2” below the lip  
• Press barriers on the skin and hold in place for 30 seconds Apply the neck band and 
secure the ET:  
• Secure the neck band using the plastic loop closures. Allow two fingers width 
between the neck band and the neck  
• Squeeze the tabs on the shuttle, moving it over the ET tube  
• Make sure the ET tube is clean and dry  
• Remove the liner from the adhesive strap and wrap it tightly around the tube  
Secure strap by snapping the clamp shut (an audible click will be heard)  
• Document the application date or change date on Carelink (Device may 
remain in place for up to 7  
days)  
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Routine Care:  
• Reposition ET tube every 4 hours or more often as condition warrants 
• Assess patient’s skin every 2 hours for irritation and increase frequency of 
repositioning if pressure  
ulcer occurs 
• Check and document every 2 hours to ensure that both the Anchor Fast 
device and the ET tube are  
secure and correctly positioned. 
• Under usual circumstances, replace the device every 3 to 7 days (or sooner if 
indicated) • Replace the neck tie when needed due to soiling  
Removal  
• Release the clamp 
• While holding the ET tube unwrap the adhesive strap 
• Release the neck band by unfastening the hook and loop closures 
• Remove the skin barriers by very gently peeling away from the patient’s skin 
to prevent injury 
• Use of a warm cloth may be helpful to loosen adhesion to skin 
• Special considerations should be taken for patients with bleeding disorders 
(i.e. thrombocytopenia)  
Reference: Refer to manufacture information. Revised 1/2013 
MICU/Respiratory Care 
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Appendix D 
 
Informed Consent 
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Appendix E 
 
Data Recording Sheets 
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Appendix F 
 
 
Reprinted with permission. 
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